Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Clinical trial NCT03602261 · TERMINATED

Trial details

NCT number: NCT03602261
Sponsor: OPKO Health, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism Due to Renal Causes Chronic Kidney Diseases Vitamin D Deficiency Stage 5 Chronic Kidney Disease

Start date: 2018-07-09
Primary completion: 2021-02-24
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.